AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35816069 — intervention group
Group type: COMPARATOR
Intervention: Nutraceutical supplement (after transitioning from placebo)
Number of subjects: 0
Study 33067310 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone 2 mg/kg (maximum 40 mg), once daily for 3 days
Number of subjects: 477
Study 33067310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 477
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian endometriotic lesions
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Eutopic endometrium
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IV ovarian endometriotic lesions
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage III ovarian endometriotic lesions
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of BDNF mRNA expression in eutopic endometrium
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of TrKB mRNA expression in eutopic endometrium
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of BDNF in eutopic and ectopic endometrium
Number of subjects: 62
Study 35300713 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of TrKB in eutopic and ectopic endometrium
Number of subjects: 62
Study 34622597 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose - Deep Learning (LD-DL)
Number of subjects: 100
Study 34622597 — intervention group
Group type: COMPARATOR
Intervention: Normal Dose - Iterative Reconstruction (ND-IR)
Number of subjects: 100
Study 34622597 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose - Filtered Back Projection (LD-FBP)
Number of subjects: 100
Study 34622597 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Dose - Iterative Reconstruction (LD-IR)
Number of subjects: 100
Study 32919454 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk
Number of subjects: 96
Study 32919454 — intervention group
Group type: COMPARATOR
Intervention: Soy milk substitute
Number of subjects: 96
Study 36122260 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral retrolaminar block with 20 mL of 0.25% bupivacaine and 5 µg/mL adrenaline (1:200000)
Number of subjects: 52
Study 36122260 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided thoracic epidural analgesia with 20 mL of 0.25% bupivacaine and 5 µg/mL adrenaline (1:200000)
Number of subjects: 52
Study 36122260 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral retrolaminar block
Number of subjects: 52
Study 36122260 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided thoracic epidural analgesia
Number of subjects: 52
Study 36122260 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 52
Study 32357109 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Messaging
Number of subjects: 301
Study 32357109 — intervention group
Group type: EXPERIMENTAL
Intervention: Teenwork (TW)
Number of subjects: 301
Study 32357109 — intervention group
Group type: EXPERIMENTAL
Intervention: TW+Text
Number of subjects: 301
Study 32357109 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 301
Study 34614195 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime compression garment plus nighttime compression bandaging
Number of subjects: 120
Study 34614195 — intervention group
Group type: EXPERIMENTAL
Intervention: Daytime compression garment plus nighttime compression system garment
Number of subjects: 120
Study 34614195 — intervention group
Group type: COMPARATOR
Intervention: Daytime compression garment alone (standard care)
Number of subjects: 120
Study 32285548 — intervention group
Group type: EXPERIMENTAL
Intervention: Colour vision testing using the Richmond Hardy-Rand-Rittler pseudoisochromatic test; diagnostic plates for determining CVD type and extent.
Number of subjects: 1626
Study 32285548 — intervention group
Group type: COMPARATOR
Intervention: Traveller participants
Number of subjects: 1626
Study 32285548 — intervention group
Group type: COMPARATOR
Intervention: Boys with CVD
Number of subjects: 1626
Study 33382189 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg-positive with high HBV DNA (≥2000 IU/ml)
Number of subjects: 879
Study 33382189 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated anti-HBcAb-positive
Number of subjects: 879
Study 33382189 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolved HBV infection (HBsAb-positive/HBcAb-positive)
Number of subjects: 879
Study 33382189 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV non-immune/vaccinated (HBcAb-negative)
Number of subjects: 879
Study 32710396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab (5 days at baseline, 3 days at 12 months)
Number of subjects: 208
Study 32710396 — intervention group
Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Number of subjects: 208
Study 34773923 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3358699 (1-40 mg)
Number of subjects: 48
Study 34773923 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3358699 (10 mg)
Number of subjects: 48
Study 34773923 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3358699 (20-40 mg)
Number of subjects: 48
Study 34773923 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3358699 (40 mg)
Number of subjects: 48
Study 34773923 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK3358699
Number of subjects: 48
Study 34773923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 34986069 — intervention group
Group type: EXPERIMENTAL
Intervention: External Control Arm (ECA) created from patient-level data from previous clinical trials or real-world data.
Number of subjects: 0
Study 34986069 — intervention group
Group type: COMPARATOR
Intervention: Randomized control arm (not explicitly detailed in the abstract).
Number of subjects: 0
Study 33752148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose carbohydrates (administered 2–3 h before surgery)
Number of subjects: 139
Study 33752148 — intervention group
Group type: COMPARATOR
Intervention: Double-dose carbohydrates (administered 10 h before surgery and 2–3 h before surgery)
Number of subjects: 139
Study 33752148 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose carbohydrates
Number of subjects: 139
Study 33752148 — intervention group
Group type: COMPARATOR
Intervention: Double-dose carbohydrates
Number of subjects: 139
Study 36453320 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term aerobic exercise (cycling at moderate intensity 20% Wmax for 10 minutes and high intensity 60% Wmax for 5 minutes)
Number of subjects: 123
Study 36453320 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term aerobic exercise (regular jogging for 30 minutes, 20 times per month for 3 months)
Number of subjects: 123
Study 36453320 — intervention group
Group type: COMPARATOR
Intervention: Control group (irregular exercise)
Number of subjects: 123
Study 33970360 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydisperse sample with avoided reconstruction mistakes
Number of subjects: 0
Study 33970360 — intervention group
Group type: COMPARATOR
Intervention: Reconstruction mistakes in measuring propensity
Number of subjects: 0
Study 32859978 — intervention group
Group type: EXPERIMENTAL
Intervention: S. epidermidis strains from endophthalmitis
Number of subjects: 0
Study 32859978 — intervention group
Group type: COMPARATOR
Intervention: S. epidermidis strains from healthy conjunctiva
Number of subjects: 0
Study 32859978 — intervention group
Group type: EXPERIMENTAL
Intervention: DEGs associated with thioredoxin system and iron ion metabolism
Number of subjects: 0
Study 32859978 — intervention group
Group type: EXPERIMENTAL
Intervention: DEGs associated with two-component system and pyruvate metabolism
Number of subjects: 0
Study 32859978 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene SE1634
Number of subjects: 0
Study 34355328 — intervention group
Group type: EXPERIMENTAL
Intervention: High pollution area (PM10: 121.44±43.49 μg/m3, PM2.5: 84.18±31.32 μg/m3)
Number of subjects: 369
Study 34355328 — intervention group
Group type: COMPARATOR
Intervention: Moderate pollution area (PM10: 89.7±37.34 μg/m3, PM2.5: 58±23.94 μg/m3)
Number of subjects: 369
Study 34355328 — intervention group
Group type: COMPARATOR
Intervention: Low pollution area (PM10: 59.14±25.24 μg/m3, PM2.5: 38.97±16.87 μg/m3)
Number of subjects: 369
Study 34522871 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine 1.66 g twice a day
Number of subjects: 101
Study 34522871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 34522871 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 101
Study 35606250 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical preparation containing 3.75mg of monacolin K, 515mg of berberine and 50mg of coenzyme Q10 per tablet (Lipok®)
Number of subjects: 0
Study 35606250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32537828 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Simple Question (SSQ)
Number of subjects: 157
Study 32537828 — intervention group
Group type: EXPERIMENTAL
Intervention: MG impairment index
Number of subjects: 157
Study 32537828 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver Operating Characteristic (ROC) curve for PASS and SSQ
Number of subjects: 157
Study 32537828 — intervention group
Group type: EXPERIMENTAL
Intervention: SSQ score threshold
Number of subjects: 157
Study 36493607 — intervention group
Group type: EXPERIMENTAL
Intervention: Culprit artery percutaneous coronary intervention during the index procedure
Number of subjects: 7473
Study 36493607 — intervention group
Group type: EXPERIMENTAL
Intervention: OCA group
Number of subjects: 7473
Study 33765860 — intervention group
Group type: EXPERIMENTAL
Intervention: PCCP training
Number of subjects: 60
Study 33765860 — intervention group
Group type: COMPARATOR
Intervention: Service planning as usual (Control)
Number of subjects: 60
Study 33177727 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anaesthesia
Number of subjects: 300
Study 33177727 — intervention group
Group type: COMPARATOR
Intervention: Natural delivery without analgesic measures
Number of subjects: 300
Study 34843987 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved primary end point of sustained corticosteroid-free clinical remission with no ulcers on ileocolonoscopy at week 54
Number of subjects: 95
Study 34843987 — intervention group
Group type: COMPARATOR
Intervention: Did not achieve primary end point of sustained corticosteroid-free clinical remission
Number of subjects: 95
Study 33647599 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab emtansine (T-DM1)
Number of subjects: 0
Study 33647599 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 0
Study 32713693 — intervention group
Group type: COMPARATOR
Intervention: Pelleted starter conditioned for 0 min (CON)
Number of subjects: 30
Study 32713693 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelleted starter conditioned for 2 min
Number of subjects: 30
Study 32713693 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelleted starter conditioned for 4 min
Number of subjects: 30
Study 35140156 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based education intervention
Number of subjects: 85
Study 35140156 — intervention group
Group type: COMPARATOR
Intervention: Standard education (Control)
Number of subjects: 85
Study 33858214 — intervention group
Group type: EXPERIMENTAL
Intervention: Concussion Cohort (24 to 48 hours post-injury)
Number of subjects: 167
Study 33858214 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconcussion Cohort (non-concussed participants with moderate or high cumulative subconcussive impact exposure)
Number of subjects: 167
Study 36095045 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Science Education (PSE)
Number of subjects: 66
Study 36095045 — intervention group
Group type: COMPARATOR
Intervention: Pathoanatomical Education (PAE)
Number of subjects: 66
Study 36095045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PSE and PAE)
Number of subjects: 66
Study 33492514 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy (APT)
Number of subjects: 160
Study 33492514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT)
Number of subjects: 160
Study 33492514 — intervention group
Group type: COMPARATOR
Intervention: Control group (no APT)
Number of subjects: 160
Study 34850238 — intervention group
Group type: EXPERIMENTAL
Intervention: digital cognitive behavior therapy for insomnia (dCBT‐I)
Number of subjects: 208
Study 34850238 — intervention group
Group type: COMPARATOR
Intervention: standard care
Number of subjects: 208
Study 32550713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 18
Study 32550713 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 18
Study 32550713 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 18
Study 35857186 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine
Number of subjects: 0
Study 35857186 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32605552 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based cooking program
Number of subjects: 0
Study 32852366 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP‐2 (INFUSE bone graft) added to standard surgical procedure
Number of subjects: 5
Study 32852366 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical procedure without rhBMP‐2
Number of subjects: 5
Study 32086189 — intervention group
Group type: EXPERIMENTAL
Intervention: SoMe social media literacy program
Number of subjects: 0
Study 32086189 — intervention group
Group type: COMPARATOR
Intervention: Health lessons as usual (control)
Number of subjects: 0
Study 36495861 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomics-guided therapies, standardized system for determining actionability of genomic alterations
Number of subjects: 0
Study 34814896 — intervention group
Group type: EXPERIMENTAL
Intervention: High Tone Power Therapy
Number of subjects: 35
Study 34814896 — intervention group
Group type: COMPARATOR
Intervention: Control group (without High Tone Power Therapy)
Number of subjects: 35
Study 32696704 — intervention group
Group type: COMPARATOR
Intervention: Sugar-Sweetened Beverages (SSBs)
Number of subjects: 203
Study 32696704 — intervention group
Group type: COMPARATOR
Intervention: Artificially Sweetened Beverages (ASBs)
Number of subjects: 203
Study 32696704 — intervention group
Group type: COMPARATOR
Intervention: Unsweetened Beverages (USBs)
Number of subjects: 203
Study 32696704 — intervention group
Group type: COMPARATOR
Intervention: Comparison between ASB and USB groups
Number of subjects: 203
Study 34575662 — intervention group
Group type: EXPERIMENTAL
Intervention: DRSS-guided management
Number of subjects: 40
Study 34575662 — intervention group
Group type: COMPARATOR
Intervention: PLI-guided management
Number of subjects: 40
Study 34575662 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 40
Study 35608001 — intervention group
Group type: EXPERIMENTAL
Intervention: Global budget intervention for county hospitals
Number of subjects: 22000000
Study 33766829 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel MR imaging scoring system for hypoxic-ischemic brain injury
Number of subjects: 252
Study 33766829 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted scoring system
Number of subjects: 252
Study 36335376 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive Outreach with Medication Opt‐out for Tobacco Treatment Engagement (PrOMOTE)
Number of subjects: 230
Study 36335376 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 230
Study 33783518 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotionally resilient phenotype (419 individuals, 23.8%)
Number of subjects: 1757
Study 33783518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively impaired phenotype (368 individuals, 20.9%)
Number of subjects: 1757
Study 33783518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively resilient phenotype (620 individuals, 35.3%)
Number of subjects: 1757
Study 33783518 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychiatrically distressed phenotype (350 individuals, 19.9%)
Number of subjects: 1757
Study 33783518 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent profile (LP) analysis
Number of subjects: 1757
Study 35802618 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative hypnosis session and post-operative web-based Acceptance and Commitment Therapy (ACT)
Number of subjects: 200
Study 35802618 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative one-session mindfulness through an audio file and post-operative treatment as usual (TAU)
Number of subjects: 200
Study 36355373 — intervention group
Group type: EXPERIMENTAL
Intervention: LINKAGE intervention (6 group-based sessions emphasizing patient agency, skill, and motivation; facilitated connection with primary care practitioner)
Number of subjects: 503
Study 36355373 — intervention group
Group type: EXPERIMENTAL
Intervention: LINKAGE intervention
Number of subjects: 503
Study 36355373 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 503
Study 33357793 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic-based learning tool for blood transfusion training
Number of subjects: 0
Study 33357793 — intervention group
Group type: COMPARATOR
Intervention: Conventional standard operational procedure
Number of subjects: 0
Study 35358441 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus rituximab (375 mg/m2 on days 3, 10, 17, and 24)
Number of subjects: 586
Study 35358441 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 586
Study 35358441 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care plus rituximab
Number of subjects: 586
Study 34824985 — intervention group
Group type: EXPERIMENTAL
Intervention: Online personalized feedback intervention
Number of subjects: 744
Study 34824985 — intervention group
Group type: COMPARATOR
Intervention: Educational materials only (Control)
Number of subjects: 744
Study 36115523 — intervention group
Group type: EXPERIMENTAL
Intervention: Deucravacitinib 6 mg daily
Number of subjects: 1020
Study 36115523 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1020
Study 36115523 — intervention group
Group type: COMPARATOR
Intervention: Apremilast 30 mg twice a day
Number of subjects: 1020
Study 32914482 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating disorders (EDs)
Number of subjects: 1657
Study 32914482 — intervention group
Group type: COMPARATOR
Intervention: Non-eating disorder controls
Number of subjects: 1657
Study 34699857 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 122
Study 34699857 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 122
Study 34699857 — intervention group
Group type: COMPARATOR
Intervention: Combination of bright light therapy and fluoxetine
Number of subjects: 122
Study 34699857 — intervention group
Group type: COMPARATOR
Intervention: Placebo-sham control
Number of subjects: 122
Study 33907251 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine 450 mg BID on day 1 and 450 mg once daily from days 2 to 5 or Hydroxychloroquine 400 mg BID on day 1 and 400 mg once daily from days 2 to 5 (combined with standard care)
Number of subjects: 105
Study 33907251 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 105
Study 33907251 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine/hydroxychloroquine (combined with standard care)
Number of subjects: 105
Study 36421046 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg
Number of subjects: 250
Study 36421046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 10 mg
Number of subjects: 250
Study 36421046 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg
Number of subjects: 250
Study 36421046 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Number of subjects: 250
Study 36421046 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 33743063 — intervention group
Group type: EXPERIMENTAL
Intervention: Single preoperative dose of 20-mg dexamethasone (Group B)
Number of subjects: 3
Study 33743063 — intervention group
Group type: EXPERIMENTAL
Intervention: Two perioperative doses of 10-mg dexamethasone (Group C)
Number of subjects: 3
Study 33743063 — intervention group
Group type: COMPARATOR
Intervention: No dexamethasone (Group A)
Number of subjects: 3
Study 33256688 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) intervention for reduction of blood pressure
Number of subjects: 0
Study 35621327 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention (16 sessions of cognitive tasks)
Number of subjects: 59
Study 35621327 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cognitive stimulation)
Number of subjects: 59
Study 33610726 — intervention group
Group type: EXPERIMENTAL
Intervention: French maritime pine bark extract (PBE) supplementation (50mg, two capsules/day for eight weeks)
Number of subjects: 46
Study 33610726 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 32511669 — intervention group
Group type: EXPERIMENTAL
Intervention: Raising Healthy Children intervention (full intervention)
Number of subjects: 182
Study 32511669 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 182
Study 36244383 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated care
Number of subjects: 1340
Study 36244383 — intervention group
Group type: EXPERIMENTAL
Intervention: Designated care
Number of subjects: 1340
Study 36244383 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1340
Study 33010148 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin treatment
Number of subjects: 486
Study 33010148 — intervention group
Group type: COMPARATOR
Intervention: No dapagliflozin treatment (Control)
Number of subjects: 486
Study 35819522 — intervention group
Group type: EXPERIMENTAL
Intervention: 30‐s sit‐to‐stand (30STS) test
Number of subjects: 120
Study 34620093 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane at concentrations of 0.3, 0.6, and 0.9 MAC
Number of subjects: 40